Vital Statistics Japan (Ministry of Health, Labour and Welfare). http://www.mhlw.go.jp/english/database/db-hw/index.html

Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K, Kai I. Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017;17:1045–7. https://doi.org/10.1111/ggi.13118.

Article  PubMed  Google Scholar 

An JK, Kang TH, Choi MG, Noh JH, Sung T, Kim S. Borrmann type IV: an independent prognosis factor for survival in gastric cancer. J Gastrointest Surg. 2008;12:1364–9. https://doi.org/10.1007/s11605-008-0516-9.

Article  PubMed  Google Scholar 

Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, Noh SH. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009;77:197–204. https://doi.org/10.1159/000236018.

Article  PubMed  Google Scholar 

Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ohigashi H, Nakamori S, Yasuda T. Extended surgery-left upper abdominal extension plus Appleby’s method-for type 4 gastric carcinoma. Ann Surg Oncol. 1997;4:209–14.

Article  CAS  PubMed  Google Scholar 

Kinoshita T, Sasako M, Sano T, Katai H, Furukawa H, Tsuburaya A, Miyashiro I, Kaji M, Ninomiya M (on behalf of the Gastric Cancer Surgery Study Group of the Japan Clinical Oncology group). Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer. 2009;12:37–42. https://doi.org/10.1007/s10120-008-0496-1.

Article  CAS  Google Scholar 

Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito S, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Lee SW, Takagane A, Yabusaki H, Hirata J, Boku N, Sano T, Sasako M. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large 3 gastric cancer (JCOG): an open-label, phase 3, randomized controlled trial. Gastric Cancer. 2021;24:492–502. https://doi.org/10.1007/s10120-020-01136-7.

Article  CAS  PubMed  Google Scholar 

Hashimoto T, Nakayama I, Ohashi M, Mizusawa J, Kawachi H, Kita R, Fukuda H, Kurokawa Y, Boku N, Yoshioka T, Terashima M. Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer. Future Oncol. 2023;19:2147–55. https://doi.org/10.2217/fon-2023-0605.

Article  CAS  PubMed  Google Scholar 

Peterson LI, Hurria A, Feng T, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Glezerman I, Katheria V, Zavala L, Smith DD, Sun CL, Tew WP. Association between renal function and chemotherapy-related toxicity in older adults with cancer. J Geriatr Oncol. 2017;8:96–101. https://doi.org/10.1016/j.jgo.2016.10.004.

Article  PubMed  Google Scholar 

Saikawa Y, Kubota T, Kumagai K, Nakamura R, Kumai K, Shigematsu N, Kubo A, Kitajima M, Kitagawa Y. Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer. Int J Radiat Oncol Biol Phys. 2008;71:173–9. https://doi.org/10.1016/j_ijrohp.2007.09.010.

Article  CAS  PubMed  Google Scholar 

Takahashi T, Saikawa Y, Takaishi H, Takeuchi H, Wada N, Oyama T, Fukuda K, Fukada J, Kawaguchi O, Shigematsu N, Kitagawa Y. Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01). Anticancer Res. 2011;31:3079–84.

CAS  PubMed  Google Scholar 

Yamashita K, Ema A, Hosoda K, Mieno H, Moriya H, Katada N, Watanabe M. Macroscopic appearance of Type IV and giant Type III is a high risk for a poor prognosis in pathological stage II/III advanced gastric cancer with postoperative adjuvant chemotherapy. World J Gastrointest Oncol. 2017;9:166–75. https://doi.org/10.4251/wjgo.v9.i4.166.

Article  PubMed  PubMed Central  Google Scholar 

U.S. Department of Health and Human Survices. National Eventns (CTCAE) version 4.0 (2009)

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12. https://doi.org/10.1007/s10120-011-0041-5.

Article  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.

Article  PubMed  PubMed Central  Google Scholar 

Koizumi W, Akiya T, Sato A, Sakuyama T, Sasaki E, Tomidokoro T, Hamada T, Fujimori M, Kikuchi Y, Shimada K, Mine T, Yamaguchi K, Sasaki T, Kurihara M. Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo cooperative oncology group study. Cancer Chemother Pharmacol. 2010;65:1093–9. https://doi.org/10.1007/s00280-009-1114-6.

Article  CAS  PubMed  Google Scholar 

Imamura H, Kishimoto T, Takiuchi H, Kimura Y, Morimoto T, Imano M, Iijima S, Yamashita K, Maruyama K, Otsuji T, Kurokawa Y, Furukawa H. Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). J Chemother. 2014;26:57–61. https://doi.org/10.1179/1973947813Y.0000000116.

Article  CAS  PubMed  Google Scholar 

Hoskovec D, Varga J, Dytrych P, Konecna E, Matek J. Peritoneal lavage examination as a prognostic tool in cases of gastric cancer. Arch Med Sci. 2017;13:612–6. https://doi.org/10.5114/aoms.2016.64044.

Article  PubMed  Google Scholar 

Kang KK, Hur H, Byun CS, Kim YB, Han SU, Cho YK. Conventional cytology is not beneficial for predicting peritoneal recurrence after curative surgery for gastric cancer: results of a prospective clinical study. J Gastric Cancer. 2014;14:23–31. https://doi.org/10.5230/jgc.2014.14.1.23.

Article  PubMed  PubMed Central  Google Scholar 

Taffon C, Giovannoni I, Mozetic P, Capolupo GT, La Vaccara V, Cinque C, Caricato C, Rainer A, Zelano G, Crescenzi A. Seriate cytology vs molecular analysis of peritoneal washing to improve gastric cancer cells detection. Diagn Cytopathol. 2019;47:670–4. https://doi.org/10.1002/dc.24165.

Article  PubMed  Google Scholar 

Terashima M, Iwasaki Y, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito Y, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Boku N, Sano T, Sasako M, Stomach Cancer Study Group, Japan Clinical Oncology Group. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan clinical oncology group study (JCOG0501). Gastric Cancer. 2019;22:1044–52. https://doi.org/10.1007/s10120-019-00941-z.

Article  CAS  Google Scholar 

Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–22. https://doi.org/10.1016/0360-3016(91)90171-y.

Article  CAS  PubMed  Google Scholar 

Timmerman R. A story of hypofractionation and the table on the wall. Int J Radiat Oncol Biol Phys. 2022;112:4–21. https://doi.org/10.1016/j.ijrobp.2021.09.027.

Article  PubMed  Google Scholar 

Tomasello G, Petrelli F, Ghidini M, Pezzica E, Passalacqua R, Steccanella F, Turati L, Sgroi G, Barni S. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies. Eur J Surg Oncol. 2017;43:1607–16. https://doi.org/10.1016/j.ejso.2017.03.001.

Article  CAS  PubMed  Google Scholar 

Lee DJ, Sohn TS, Lim DH, Ahn HK, Park SH, Lee J, Park JO, Park YS, Lim HY, Choi DI, Kim KM, Choi MG, Noh JH, Bae JM, Kim S, Min BH, Kang WK. Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol. 2012;69:1333–8. https://doi.org/10.1007/s00280-012-1836-8.

Article  CAS  PubMed  Google Scholar 

Inoue T, Yachida S, Usuki H, Kimura T, Hagiike M, Okano K, Suzuki Y. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. Ann Surg Oncol. 2012;19:2937–45. https://doi.org/10.1245/s10434-012.2332-4.

Article  PubMed  Google Scholar